Rationale And Objectives: This study aimed to create a radiomics nomogram using grayscale ultrasound (US) to predict human epidermal growth factor receptor 2 (HER-2) expression status preoperatively in invasive breast cancer (IBC) patients.
Materials And Methods: The study population was randomly divided into a training dataset (360 patients, 99 HER-2-positive) and a validation dataset (155 patients, 42 HER-2-positive). Clinical data, including US features, were collected. Radiomics features were extracted from grayscale US images, followed by feature selection to establish a radiomics score (Radscore) model. Univariate and multivariate logistic regression analyses identified independent risk factors for the clinical and radiomics nomogram models. Model performance was evaluated using receiver operating characteristic curves, calibration curves, decision curve analysis, net reclassification improvement, and integrated discrimination improvement.
Results: 16 radiomics features were selected for the Radscore model. Tumor margin and calcification emerged as significant preoperative risk factors for HER-2 status, forming the basis of a clinical prediction model. The integrated radiomics nomogram, combining tumor margin, calcification, and Radscore, demonstrated strong discrimination with area under the curve values of 0.810 in the training dataset and 0.807 in the validation dataset.
Conclusion: The US-based radiomics nomogram shows substantial promise for preoperatively predicting HER-2 status in IBC patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2024.12.059 | DOI Listing |
Int J Gen Med
March 2025
Medical Imaging Center, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi Province, People's Republic of China.
Background: Cervical cancer remains a major cause of mortality among women globally, with lymph node metastasis (LNM) being a critical determinant of patient prognosis.
Methods: In this study, MRI scans from 153 cervical cancer patients between January 2018 and January 2024 were analyzed. The patients were assigned to two groups: 103 in the training cohort; 49 in the validation cohort.
Cancer Imaging
March 2025
Department of Radiology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, Shandong, 266003, China.
Background: To construct and assess a deep learning (DL) signature that employs computed tomography imaging to predict the expression status of programmed cell death ligand 1 in patients with bladder cancer (BCa).
Methods: This retrospective study included 190 patients from two hospitals who underwent surgical removal of BCa (training set/external validation set, 127/63). We used convolutional neural network and radiomics machine learning technology to generate prediction models.
BMC Med Imaging
March 2025
Imaging Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011, Xinjiang, China.
Objectives: To evaluate the performance of CT-based intralesional combined with different perilesional radiomics models in predicting the microvascular density (MVD) of hepatic alveolar echinococcosis (HAE).
Methods: This study retrospectively analyzed preoperative CT data from 303 patients with HAE confirmed by surgical pathology (MVD positive, n = 182; MVD negative, n = 121). The patients were randomly divided into the training cohort (n = 242) and test cohort (n = 61) at a ratio of 8:2.
PLoS One
March 2025
Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Objective: To develop a non-contrast CT based multi-regional radiomics model for predicting contrast medium (CM) extravasation in patients with tumors.
Methods: A retrospective analysis of non-contrast CT scans from 282 tumor patients across two medical centers led to the development of a radiomics model, using 157 patients for training, 68 for validation, and 57 from an external center as an independent test cohort. The different volumes of interest from right common carotid artery/right internal jugular vein, right subclavian artery/vein and thoracic aorta were delineated.
J Immunother Cancer
March 2025
Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China
Background: Current prognostic and predictive biomarkers for lung adenocarcinoma (LUAD) predominantly rely on unimodal approaches, limiting their characterization ability. There is an urgent need for a comprehensive and accurate biomarker to guide individualized adjuvant therapy decisions.
Methods: In this retrospective study, data from patients with resectable LUAD (stage I-III) were collected from two hospitals and a publicly available dataset, forming a training dataset (n=223), a validation dataset (n=95), a testing dataset (n=449), and the non-small cell lung cancer (NSCLC) Radiogenomics dataset (n=59).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!